Bionano Genomics, Inc.
Bionano Genomics, Inc. (BNGO) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · BNGO · as of Sep 30, 2025
Ownership Breakdown
30
Institutional Holders
▲ 2 vs Q2
$417,232
Total Inst. Value
▲ $88,252 vs Q2
3.28M
Shares Outstanding
freeFloat 99.64%
244,407
13F Shares Held
▲ 143,960 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
BNGO largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
UBS GROUP AG laboratory analytical instruments | 63.9K | 1.86% | 1.86% | $109.23M | Nov 13, 2025 | ▲ 61.2K |
VANGUARD GROUP INC laboratory analytical instruments | 50.5K | 1.47% | 1.47% | $86.28M | Nov 7, 2025 | ▲ 50.5K |
GEODE CAPITAL MANAGEMENT, LLC laboratory analytical instruments | 26.8K | 77.99% | 77.99% | $45.90M | Nov 12, 2025 | ▲ 8.0K |
CARRET ASSET MANAGEMENT, LLC laboratory analytical instruments | 25.0K | 72.65% | 72.65% | $42.75M | Nov 13, 2025 | NEW |
HRT FINANCIAL LP laboratory analytical instruments | 20.3K | 59.08% | 59.08% | $34.00M | Nov 14, 2025 | NEW |
TWO SIGMA SECURITIES, LLC laboratory analytical instruments | 15.6K | 45.29% | 45.29% | $26.65M | Nov 14, 2025 | NEW |
STIFEL FINANCIAL CORP laboratory analytical instruments | 10.5K | 30.55% | 30.55% | $17.98M | Nov 12, 2025 | NEW |
BLACKROCK, INC. laboratory analytical instruments | 9.9K | 28.88% | 28.88% | $16.99M | Nov 12, 2025 | ▲ 1 |
BANK OF AMERICA CORP /DE/ laboratory analytical instruments | 8.5K | 24.72% | 24.72% | $14.55M | Feb 3, 2026 | ▲ 98 |
MORGAN STANLEY laboratory analytical instruments | 6.2K | 18.04% | 18.04% | $10.62M | May 27, 2026 | ▼ 5.4K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
7
Increased
+120.9K shares6
New Positions
first time holders7
Decreased
−8.0K shares6
Sold Out
fully exitedNet shares change (top 50)
+112.9K
+120.9K / −8.0K
Net new holders
+0
6 new / 6 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
BNGO insider trading · insider activity
Source: SEC Form 4
5
Buy transactions
4
Sell transactions
1.25
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Dixon Jonathan V. GENERAL COUNSEL | Jun 3, 2026 | Tax Withhold | 24 | $1.30 | $31.2 | 239 | Form 4 ↗ |
OLDAKOWSKI MARK CHIEF OPERATING OFFICER | Jun 3, 2026 | Tax Withhold | 27 | $1.30 | $35.1 | 868 | Form 4 ↗ |
Chaubey Alka CHIEF MEDICAL OFFICER | Jun 3, 2026 | Tax Withhold | 24 | $1.30 | $31.2 | 620 | Form 4 ↗ |
Adamchak Mark Principal Accounting Officer | Jun 3, 2026 | Tax Withhold | 7 | $1.30 | $9.1 | 253 | Form 4 ↗ |
Rajkovic Aleksandar director | May 14, 2026 | Award | 9,149 | $1.19 | $10.9K | 9.1K | Form 4 ↗ |
Linney Yvonne director | May 14, 2026 | Award | 9,149 | $1.19 | $10.9K | 9.1K | Form 4 ↗ |
Vuori Kristiina MD director | May 14, 2026 | Award | 9,149 | $1.19 | $10.9K | 9.1K | Form 4 ↗ |
TWOMEY CHRISTOPHER J director | May 14, 2026 | Award | 9,149 | $1.19 | $10.9K | 9.1K | Form 4 ↗ |
BARKER DAVID L director | May 14, 2026 | Award | 9,149 | $1.19 | $10.9K | 9.1K | Form 4 ↗ |
Chaubey Alka CHIEF MEDICAL OFFICER | Feb 17, 2026 | Tax Withhold | 18 | $1.10 | $19.8 | 644 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Bionano Genomics, Inc. (BNGO) is primarily owned by institutional investors, who hold approximately 7.4% of total shares outstanding. Company insiders own approximately 0.36%, while retail and public investors account for the remaining 92.20%.
The largest institutional shareholder of Bionano Genomics, Inc. is UBS GROUP AG, holding approximately 63,876 shares — equal to 1.86% of outstanding shares — as of September 30, 2025.
A total of 30 institutional investors currently hold BNGO stock, with a combined institutional value of approximately $417,232 as of the most recent 13F filing period.
Frequently asked questions
BNGO ownershipBionano Genomics, Inc. (BNGO) is primarily owned by institutional investors, who hold approximately 7.4% of shares. The largest shareholder is UBS GROUP AG with a 1.86% stake. Company insiders hold 0.36%. Data sourced from SEC Form 13F as of September 30, 2025.